REG - Schroder UK Mid - Compliance with Market Abuse Regulation

Schroder UK Mid Cap FundAnnouncement

02/06/2025 14:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250602:nRSB0645La&default-theme=true

RNS Number : 0645L  Schroder UK Mid Cap Fund PLC  02 June 2025

2 June 2025

 

SCHRODER UK MID CAP FUND PLC

 

(the "Company")

 

Compliance with the Market Abuse Regulation ("MAR")

 

 

The Company announces that it is satisfied that all inside information which
the Directors and the Company may have in the period leading up to the
announcement of its half year results for the period ended 31 March 2025 has
previously been, and will continue to be, notified via a regulatory
information service ("RIS"). Therefore, the Company is not prohibited from
dealing in its own securities.

 

The mandatory closed period under MAR will last until the half year results in
respect of the period ended 31 March 2025 are published and is anticipated to
end no sooner than 30 June 2025.

 

If, in the period leading up to the announcement of the half year results, the
Directors of the Company come into the possession of any inside information,
this will be notified to an RIS before any such transactions are undertaken.

 

Enquiries:

 

Schroder Investment Management Limited

Phoebe Merrell / Katherine Fyfe

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRFLFIVRLIFIIE